Acceleron is committed to developing novel protein therapeutics for orphan diseases and cancer.

Acceleron’s scientific approach takes advantage of its unique insight to discover first-in-class therapies based on the TGF-ß protein superfamily. Acceleron utilizes proven biotherapeutic technologies and capitalizes on the company’s internal GMP manufacturing capability to advance its therapeutic programs rapidly and efficiently.

Contact Info

128 Sidney Street, Cambridge, MA, 02139
Tel: 617-649-9200

Polaris Lead

Terry McGuire

Follow on TwitterVisit our Twitter page
Social Media